- Home
- FHTX vs GWRS Comparison
FHTX vs GWRS Comparison
Compare FHTX & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- GWRS
- Stock Information
- Founded
- FHTX 2015
- GWRS 2003
- Country
- FHTX United States
- GWRS United States
- Employees
- FHTX N/A
- GWRS N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- GWRS Water Supply
- Sector
- FHTX Health Care
- GWRS Utilities
- Exchange
- FHTX Nasdaq
- GWRS Nasdaq
- Market Cap
- FHTX 278.1M
- GWRS 268.4M
- IPO Year
- FHTX 2020
- GWRS 2010
- Fundamental
- Price
- FHTX $5.06
- GWRS $9.66
- Analyst Decision
- FHTX Strong Buy
- GWRS
- Analyst Count
- FHTX 6
- GWRS 0
- Target Price
- FHTX $11.33
- GWRS N/A
- AVG Volume (30 Days)
- FHTX 87.3K
- GWRS 50.5K
- Earning Date
- FHTX 08-05-2025
- GWRS 08-13-2025
- Dividend Yield
- FHTX N/A
- GWRS 3.14%
- EPS Growth
- FHTX N/A
- GWRS N/A
- EPS
- FHTX N/A
- GWRS 0.22
- Revenue
- FHTX $24,173,000.00
- GWRS $54,270,000.00
- Revenue This Year
- FHTX $43.75
- GWRS $8.11
- Revenue Next Year
- FHTX $1.27
- GWRS $6.71
- P/E Ratio
- FHTX N/A
- GWRS $44.36
- Revenue Growth
- FHTX N/A
- GWRS 4.33
- 52 Week Low
- FHTX $2.95
- GWRS $9.37
- 52 Week High
- FHTX $10.25
- GWRS $13.98
- Technical
- Relative Strength Index (RSI)
- FHTX 47.33
- GWRS 47.01
- Support Level
- FHTX $5.16
- GWRS $9.63
- Resistance Level
- FHTX $5.63
- GWRS $10.10
- Average True Range (ATR)
- FHTX 0.35
- GWRS 0.24
- MACD
- FHTX 0.01
- GWRS 0.00
- Stochastic Oscillator
- FHTX 38.83
- GWRS 18.99
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operates within the State of Arizona.